Synvivia

About Synvivia

Synvivia engineers molecules to reprogram cells, enabling precise control of biological functions through small molecules. This technology allows for targeted manipulation of cellular behavior, addressing challenges in synthetic biology and therapeutic development.

```xml <problem> Current methods of controlling cell behavior in synthetic biology and therapeutic development lack the precision needed for targeted manipulation of cellular functions. Existing technologies struggle to achieve fine-tuned control over specific biological processes within cells. </problem> <solution> Synvivia develops engineered molecules that enable the precise reprogramming of cells, allowing for targeted control of biological functions through small molecules. Their technology facilitates the manipulation of cellular behavior by creating custom molecules that interact with specific cellular pathways. This approach allows researchers and drug developers to influence cellular processes with greater accuracy and control compared to traditional methods. Synvivia's platform offers a way to design and implement sophisticated control mechanisms within cells, opening new possibilities for synthetic biology and therapeutic interventions. </solution> <features> - Engineered molecules for reprogramming cellular behavior - Precise control of biological functions through small molecules - Targeted manipulation of cellular pathways - Custom molecule design for specific cellular interactions </features> <target_audience> Synvivia's primary customers are researchers and drug developers in the fields of synthetic biology and therapeutics. </target_audience> ```

What does Synvivia do?

Synvivia engineers molecules to reprogram cells, enabling precise control of biological functions through small molecules. This technology allows for targeted manipulation of cellular behavior, addressing challenges in synthetic biology and therapeutic development.

Where is Synvivia located?

Synvivia is based in Berkeley, United States.

When was Synvivia founded?

Synvivia was founded in 2016.

How much funding has Synvivia raised?

Synvivia has raised 375910.

Location
Berkeley, United States
Founded
2016
Funding
375910
Employees
5 employees
Major Investors
National Science Foundation, Y Combinator, Creative Ventures, For Good Ventures, California Innovation Fund

Find Investable Startups and Competitors

Search thousands of startups using natural language

Synvivia

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Synvivia engineers molecules to reprogram cells, enabling precise control of biological functions through small molecules. This technology allows for targeted manipulation of cellular behavior, addressing challenges in synthetic biology and therapeutic development.

synvivia.com200+
cb
Crunchbase
Founded 2016Berkeley, United States

Funding

$

Estimated Funding

$300K+

Major Investors

National Science Foundation, Y Combinator, Creative Ventures, For Good Ventures, California Innovation Fund

Team (5+)

No team information available.

Company Description

Problem

Current methods of controlling cell behavior in synthetic biology and therapeutic development lack the precision needed for targeted manipulation of cellular functions. Existing technologies struggle to achieve fine-tuned control over specific biological processes within cells.

Solution

Synvivia develops engineered molecules that enable the precise reprogramming of cells, allowing for targeted control of biological functions through small molecules. Their technology facilitates the manipulation of cellular behavior by creating custom molecules that interact with specific cellular pathways. This approach allows researchers and drug developers to influence cellular processes with greater accuracy and control compared to traditional methods. Synvivia's platform offers a way to design and implement sophisticated control mechanisms within cells, opening new possibilities for synthetic biology and therapeutic interventions.

Features

Engineered molecules for reprogramming cellular behavior

Precise control of biological functions through small molecules

Targeted manipulation of cellular pathways

Custom molecule design for specific cellular interactions

Target Audience

Synvivia's primary customers are researchers and drug developers in the fields of synthetic biology and therapeutics.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.